Platinum Investment Management Ltd. Reduces Position in Esperion Therapeutics, Inc. (NASDAQ:ESPR)

Platinum Investment Management Ltd. lessened its holdings in shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) by 11.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,810,555 shares of the biopharmaceutical company’s stock after selling 378,962 shares during […]

Leave a Reply

Your email address will not be published.

Previous post Platinum Investment Management Ltd. Acquires 1,596,332 Shares of Gossamer Bio, Inc. (NASDAQ:GOSS)
Next post Trip.com Group Limited (NASDAQ:TCOM) Shares Sold by Platinum Investment Management Ltd.